B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityThe future of biologic agents in the treatment of Sjögren's syndromeNovel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat modelGraves' ophthalmopathyBAFF and rheumatic autoimmune disorders: implications for disease management and therapyImmunotherapeutic mechanisms of anti-CD20 monoclonal antibodies.Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.The potential effect of statins on rituximab immunotherapy.Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease.The potential utility of B cell-directed biologic therapy in autoimmune diseases.Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsIL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsAutoimmunity as a predisposition for infectious diseasesDesign of targeted B cell killing agents.Novel applications of Rituximab in dermatological disordersNon-infectious pulmonary toxicity of rituximab: a systematic review.High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis.Clearance of pathological antibodies using biomimetic nanoparticles.Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.Influence of BLK polymorphisms on the risk of rheumatoid arthritis.Blister-inducing antibodies target multiple epitopes on collagen VII in mice.Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosusTreatment of systemic lupus erythematosus with epratuzumab.Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse.Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.Accumulation of self-reactive naïve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjögren's syndrome.B lymphocytes: how they develop and function.Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys.Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid jointRecipient B cells are not required for graft-versus-host disease induction.Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease
P2860
Q22306446-E4CEEDF4-B616-4A46-9F3E-871283B42B2DQ24681044-3FA7183F-14AF-4DEE-A880-6C8A6F933A52Q27315858-B032851D-437D-45F9-A7D7-E8EAA0F0BD95Q28274196-AC2FA7FD-E044-4D4D-A30D-DE2E30C557D8Q28292058-B277EB35-18FD-41A8-8270-E75115DC54DEQ30439017-43F6EF2E-D089-43F3-8F4E-1204307C7741Q31039549-709BDA77-0052-429B-A30B-D7F593A5EA30Q33300467-B91EC9B6-34A0-40F8-853C-E3FE12392CDEQ33325581-1994DA9B-B709-4E62-990C-B5D140E32055Q33361951-2E6BB3C5-2EF9-40C5-93B4-CC52F05FFDA6Q33377109-43AEA70B-0CC0-457E-B3D1-6ECED73762D9Q33379103-BC6F8D0E-E409-4305-8B3A-B24E2A973BD2Q33385389-45D34C47-B4AF-41C7-8E5C-E2855DE67282Q33397525-395764EC-D172-43AE-8EA7-D4CFA6FFDB90Q33399722-4CB4A40C-21DE-4DE6-810B-C42749881300Q33404838-98EBAC8F-38B4-4CA7-B8F4-162C16043295Q33405115-0825998E-1D9E-495D-937A-D21EACE0E96CQ33408621-CFBE9E17-4D0A-425E-A71B-98AA576F9FDAQ33488520-4851E663-0186-4CA7-8DDE-C2F38269FC3AQ33747588-B2183169-A2FD-40CD-96D0-B9420C628A1AQ33934041-A187A1CC-6962-43DF-809B-1CFA3E6C9C96Q34087599-26AE8A3D-1552-4AF8-ADD9-2CDC55AAE2BFQ34096300-841B75AA-D585-4140-A530-C8E28B99D852Q34135089-47F1FE38-472B-4FFD-9BE5-08C0633BC02DQ34184264-0AC79884-AF6D-4661-A0A5-3B0A9802D8CAQ34218004-53B2498F-B2E4-49F4-A973-5A72C6F6E4C0Q34222399-FD9BBDA3-4124-455F-88F3-7701FB732C35Q34275410-A25820C5-62D8-42C7-B05C-ED62F5FDAF04Q34319443-6AECC13A-3A60-45F5-967A-23616F99839DQ34336809-363BC21C-28E0-42AB-A1A9-412CD5E4E195Q34551268-61B469AE-8365-47D9-ABE9-8BD648CCCB1BQ34580559-B50B8A46-EB15-415B-854E-2AD1553DC70FQ34684829-5D13FB77-D95D-4EED-829D-FF2FA9E8F544Q34706667-BD610583-88C2-4805-AF0D-EA36D462FDE6Q34764607-41AEADCB-78CF-4F29-ACA9-58DA8A324E4AQ34813171-C475EEE1-2A55-4CE2-9B58-25A2505C8AFAQ34979203-18EFD314-D88D-4A19-9899-5FAC4214A3EDQ35094171-9B5FE6C9-38E3-461C-B05C-4CB4280202DAQ35104223-341FB4AD-3807-416D-AC02-F652DF6D137CQ35115477-74D20714-891A-43EC-879A-69858D806F94
P2860
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@ast
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@en
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@nl
type
label
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@ast
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@en
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@nl
prefLabel
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@ast
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@en
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@nl
P356
P1476
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
@en
P2093
Geraldine Cambridge
Jonathan C W Edwards
P2860
P304
P356
10.1038/NRI1838
P577
2006-05-01T00:00:00Z